These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8380524

  • 21. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
    Agid Y, Ruberg M, Javoy-Agid F, Hirsch E, Raisman-Vozari R, Vyas S, Faucheux B, Michel P, Kastner A, Blanchard V.
    Adv Neurol; 1993; 60():148-64. PubMed ID: 8420132
    [No Abstract] [Full Text] [Related]

  • 22. [Association between genetic polymorphism of dopamine transporter gene and susceptibility to Parkinson's disease].
    Wang J, Liu Z, Chen B.
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):346-8. PubMed ID: 11798784
    [Abstract] [Full Text] [Related]

  • 23. [Behavioral, cellular and molecular consequences of the dopamine transporter gene inactivation].
    Jaber M, Bloch B, Caron MG, Giros B.
    C R Seances Soc Biol Fil; 1998 May; 192(6):1127-37. PubMed ID: 10101608
    [Abstract] [Full Text] [Related]

  • 24. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB, McConkey F, Liu F, Man HY, Lee FJ, Wang YT, Niznik HB.
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [Abstract] [Full Text] [Related]

  • 25. Neurobiology. Dopamine's reversal of fortune.
    Blakely RD.
    Science; 2001 Sep 28; 293(5539):2407-9. PubMed ID: 11577225
    [No Abstract] [Full Text] [Related]

  • 26. No evidence of association between a dopamine transporter gene polymorphism (1215A/G) and Parkinson's disease.
    Kimura M, Matsushita S, Arai H, Takeda A, Higuchi S.
    Ann Neurol; 2001 Feb 28; 49(2):276-7. PubMed ID: 11220753
    [No Abstract] [Full Text] [Related]

  • 27. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
    Dutta AK, Xu C, Reith ME.
    J Med Chem; 1998 Aug 13; 41(17):3293-7. PubMed ID: 9703474
    [Abstract] [Full Text] [Related]

  • 28. [Association between dopamine transporter gene polymorphism and Parkinson's disease].
    Zhang L, Shao M, Xu Q, Dong X, Yang J, Li Y, Chen B.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec 13; 18(6):431-4. PubMed ID: 11774209
    [Abstract] [Full Text] [Related]

  • 29. [Aminetransporters].
    Shimada S.
    Tanpakushitsu Kakusan Koso; 1997 Feb 13; 42(3 Suppl):244-52. PubMed ID: 9162958
    [No Abstract] [Full Text] [Related]

  • 30. Dopamine receptors in Parkinson's disease: imaging studies.
    Stoessl AJ, de la Fuente-Fernández R.
    Adv Neurol; 2003 Feb 13; 91():65-71. PubMed ID: 12442664
    [No Abstract] [Full Text] [Related]

  • 31. Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: no association found.
    Mercier G, Turpin JC, Lucotte G.
    J Neurol; 1999 Jan 13; 246(1):45-7. PubMed ID: 9987713
    [Abstract] [Full Text] [Related]

  • 32. Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease.
    Higuchi S, Muramatsu T, Arai H, Hayashida M, Sasaki H, Trojanowski JQ.
    J Neural Transm Park Dis Dement Sect; 1995 Jan 13; 10(2-3):107-13. PubMed ID: 9620058
    [Abstract] [Full Text] [Related]

  • 33. Association of the dopamine transporter gene with Parkinson's disease in Korean patients.
    Kim JW, Kim DH, Kim SH, Cha JK.
    J Korean Med Sci; 2000 Aug 13; 15(4):449-51. PubMed ID: 10983695
    [Abstract] [Full Text] [Related]

  • 34. Images in neuroscience. Molecular biology, II. A dopamine transporter mouse knockout.
    Caron MG.
    Am J Psychiatry; 1996 Dec 13; 153(12):1515. PubMed ID: 8942444
    [No Abstract] [Full Text] [Related]

  • 35. The dopamine transporter gene and PD in a Chinese population.
    Rafael H, Moromizato P, Ayulo V.
    Neurology; 1999 Jan 15; 52(2):429-30. PubMed ID: 9932983
    [No Abstract] [Full Text] [Related]

  • 36. The dopamine transporter gene and Parkinson's disease in a Chinese population.
    Leighton PW, Le Couteur DG, Pang CC, McCann SJ, Chan D, Law LK, Kay R, Pond SM, Woo J.
    Neurology; 1997 Dec 15; 49(6):1577-9. PubMed ID: 9409349
    [Abstract] [Full Text] [Related]

  • 37. Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease.
    Caronti B, Antonini G, Calderaro C, Ruggieri S, Palladini G, Pontieri FE, Colosimo C.
    J Neural Transm (Vienna); 2001 Dec 15; 108(7):803-7. PubMed ID: 11515746
    [Abstract] [Full Text] [Related]

  • 38. Inactivation of the dopamine transporter reveals essential roles of dopamine in the control of locomotion, psychostimulant response, and pituitary function.
    Fumagalli F, Jones S, Bossé R, Jaber M, Giros B, Missale C, Wightman RM, Caron MG.
    Adv Pharmacol; 1998 Dec 15; 42():179-82. PubMed ID: 9327873
    [No Abstract] [Full Text] [Related]

  • 39. The psychobiological regulation of social cooperation.
    Cloninger CR.
    Nat Med; 1995 Jul 15; 1(7):623-5. PubMed ID: 7585135
    [No Abstract] [Full Text] [Related]

  • 40. Resolution of biogenic amine transporter kinetics by rotating disk electrode voltammetry: methodology and mechanistic interpretations.
    Earles C, Wayment H, Green M, Schenk JO.
    Methods Enzymol; 1998 Jul 15; 296():660-75. PubMed ID: 9779481
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.